De Quervain Disease
15
2
2
8
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
13.3%
2 terminated out of 15 trials
80.0%
-6.5% vs benchmark
13%
2 trials in Phase 3/4
13%
1 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (15)
De Quervain's Disease in the Acute Phase:a Study Aimed at Evaluating the Effectiveness of Standard Physiotherapy Treatment (HANDGUIDE), Compared to Experimental Treatment After Performing Ultrasound-guided Infiltrative Therapy.
Understanding Patient Preferences When Deciding on a Voluntary Musculoskeletal Test
Impact of Gel Aromatherapy on Pain for Patients With De Quervain Disease
The Correlation of Clinical and Ultrasonographic Findings in Dorsoradial Wrist Pain Patients: Cross Sectional Study
Efficacy of Extracorporeal Shockwave Therapy on Ultrasonographic Changes in de Quervain Tenosynovitis
Correlation Between EPB Entrapment Test and Ultrasound Wrist Findings in Patients With deQuervain's Disease
Effect of Ultrasound-guided Corticosteroid Injection Versus Palpation-guided Injection for de Quervain's Disease
Comparative Effects of Paraffin Bath Therapy and ESWT on Quality of Life and Sleep in De Quervain Tenosynovitis
Comparative Effects of Paraffin Bath Therapy and ESWT in Patients With De Quervain Tenosynovitis
Effectiveness of High-intensity Laser Therapy in De Quervain Tenosynovitis
Treating Depression in Patients With De Quervain's Tenosynovitis; An Integrated Web Based Skills Intervention
Steroid Injection in De Quervain Tenosynovitis
Evaluation of Effectiveness of Local Anesthetic Injection in Patients With De Quervain Tenosynovitis
Ibuprofen Plus Acetaminophen Versus Oxycodone Alone After Hand Surgery
Post-operative Analgesia in Elective, Soft-tissue Hand Surgery